ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
出版年份 2015 全文链接
标题
ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
作者
关键词
-
出版物
OncoImmunology
Volume 5, Issue 5, Pages e1123367
出版商
Informa UK Limited
发表日期
2015-12-30
DOI
10.1080/2162402x.2015.1123367
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of NKG2D ligand expression on host immune responses
- (2015) Marine Champsaur et al. IMMUNOLOGICAL REVIEWS
- Expression of tumour necrosis factor-α and its receptors in Hodgkin lymphoma
- (2014) Shoko Nakayama et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer
- (2014) Achilleas D. Theocharis et al. FEBS Journal
- Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor V 2 T lymphocytes in non-Hodgkin lymphomas
- (2013) A. Musso et al. HAEMATOLOGICA
- Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17
- (2013) Guranda Chitadze et al. INTERNATIONAL JOURNAL OF CANCER
- Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models
- (2013) Elisa Nuti et al. JOURNAL OF MEDICINAL CHEMISTRY
- High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas
- (2011) M. R. Zocchi et al. BLOOD
- The “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: Novel drug targets with therapeutic potential?
- (2010) Paul Saftig et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cells
- (2010) Alessandro Poggi et al. INTERNATIONAL JOURNAL OF CANCER
- Potent Arylsulfonamide Inhibitors of Tumor Necrosis Factor-α Converting Enzyme Able to Reduce Activated Leukocyte Cell Adhesion Molecule Shedding in Cancer Cell Models
- (2010) Elisa Nuti et al. JOURNAL OF MEDICINAL CHEMISTRY
- The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia
- (2010) H Nückel et al. LEUKEMIA
- γδ T Cells and the Lymphoid Stress-Surveillance Response
- (2009) Adrian C. Hayday IMMUNITY
- Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
- (2009) A Poggi et al. LEUKEMIA
- Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor
- (2008) L. Witters et al. CANCER RESEARCH
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
- ADAM10 as a Target for Anti-Cancer Therapy
- (2008) Marcia Moss et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
- (2008) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Emerging roles of ADAM and ADAMTS metalloproteinases in cancer
- (2007) N. Rocks et al. BIOCHIMIE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started